Double-blind, randomised placebo-controlled, adaptive phase iib trial with vafidemstat in borderline personality disorder – aggregated baseline characteristics/demographics and safety

Autor: Ropacki, M., Gutierrez, S., Domilici, D., Lauterbach, E., Ferrer, M., Liebowitz, M., Donchev, T., Dutina, A., Brenner, R., Kozhuharov, H., Rosenberg, L., Ivkovic, M., Soefje, S., Grant, J., Faller, D.

Publikováno v: In Neuroscience Applied 2023 2 Supplement 2

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Protocol of the Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research (CHARIOT): Prospective Readiness cOhort (PRO) SubStudy.

Autor: Udeh-Momoh CT; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK.; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Watermeyer T; Department of Psychology, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.; Edinburgh Dementia Prevention, Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK., Price G; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK., de Jager Loots CA; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK., Reglinska-Matveyev N; Edinburgh Dementia Prevention, Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK., Ropacki M; Janssen Research and Development, Fremont, California, USA., Ketter N; Janssen Alzheimer Immunotherapy Research and Development LLC, South San Francisco, California, USA., Fogle M; Janssen Research and Development LLC, Titusville, New Jersey, USA., Raghavan N; Janssen Research and Development LLC, Titusville, New Jersey, USA., Arrighi M; Janssen Research and Development, Fremont, California, USA., Brashear R; Janssen Alzheimer Immunotherapy Research and Development LLC, South San Francisco, California, USA., Di J; Department of Biostatistics, Janssen Research and Development Shanghai, Shanghai, China., Baker S; Janssen Research and Development LLC, Titusville, New Jersey, USA., Giannakopoulou P; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK., Robb C; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK., Bassil D; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK., Cohn M; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK., McLellan-Young H; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK., Crispin J; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK., Lakey K; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK., Lisa C; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK., Chowdary Seemulamoodi Y; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK., Kafetsouli D; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK., Perera D; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK., Car J; Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK.; Centre for Population Health Sciences (CePHaS), Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore., Majeed A; Department of Primary Care and Public Health, School of Public, Imperial College London, London, UK., Ward H; Department of Epidemiology and Biostatistics, School of Public, Imperial College London, London, UK., Ritchie K; Edinburgh Dementia Prevention, Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK.; Neuropsychiatry: Epidemiological and Clinical Research, INSERM, University of Montpellier, Montpellier, France., Perneczky R; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK.; Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University Munich, Munchen, Germany., Kivipelto M; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK.; Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden., Scott D; BioClinica Inc Newark California Office, Newark, California, USA., Bracoud L; BioClinica Inc, Lyon, France., Saad Z; Janssen Research and Development, Fremont, California, USA., Novak G; Janssen Research and Development LLC, Titusville, New Jersey, USA GNovak1@its.jnj.com., Ritchie CW; Edinburgh Dementia Prevention, Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK., Middleton L; Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK.

Publikováno v: BMJ open [BMJ Open] 2021 Jun 24; Vol. 11 (6), pp. e043114. Date of Electronic Publication: 2021 Jun 24.

P2.12-04 CLEPSIDRA: A Phase II Trial Combining Iadademstat with Platinum-Etoposide in Platinum-Sensitive Relapsed SCLC Patients

Autor: Ropacki, M., Navarro, A., Maes, T., Gutierrez, S., Bullock, R., Buesa, C.

Publikováno v: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S813-S813

P.3.f.022 - Subjective interview quality metrics predict scoring performance in the administration of the PANSS

Autor: Negash, S., Echevarria, B., Stein, L., Prochnik, E., Ropacki, M.

Publikováno v: In European Neuropsychopharmacology October 2017 27 Supplement 4:S980-S981